Suppression of aldosterone and progesterone in preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 11, 2015, Pages 1296-1301

  Uddin, Mohammad N ^a   Horvat, Darijana ^a   Jones, Richard O ^a   Beeram, Madhava R ^a   Zawieja, David C ^a   Perger, Lena ^a   Sprague, David C C ^b   Kuehl, Thomas J ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Undergraduate Research Program   (United States)

Author keywords

Aldosterone; preeclampsia; pregnancy; progesterone

Indexed keywords

ALDOSTERONE; PROGESTERONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; NONHUMAN; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE URINE LEVEL; PROTEINURIA; RAT;

EID: 84941082934     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.951627     Document Type: Article

References (30)

1. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.
2. Pridjian G, Puschett JB. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv 2002;57:598-618.
3. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
4. Pridjian G, Puschett JB. Preeclampsia. Part 2: experimental and genetic considerations. Obstet Gynecol Surv 2002;57:619-40.
5. Vu HV, Ianosi-Irimie MR, Pridjian CA, et al. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005;25:520-8.
6. Uddin MN, Agunanne E, Horvat D, Puschett JB. Alterations in the renin-angiotensin system in a rat model of human preeclampsia. Am J Nephrol 2010;31:171-7.
7. th ed. Philadelphia (PA): Saunders/Elsevier; 2010.
8. Tuckey RC. Progesterone synthesis by the human placenta. Placenta 2005;26:273-81.
9. Aspillaga M, Whittker PG, Grey CE, Lind T. Endocrinologic events in early pregnancy failure. A J Obstet Gynecol 1983;147:903-8.
10. Escher G, Mohaupt M. Role of aldosterone availability in preeclampsia. Mol Aspects Med 2007;28:245-54.
11. Bussen SS, Sütterlin MW, Steck T. Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. Acta Obstet Gynecol Scand 1998;77:609-13.
12. August P, Lenz T, Ales KL, et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990;163:1612-21.
13. Risberg A, Olsson K, Lyrenas S, Sjöquist M. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 2009;88:639-46.
14. Brown MA, Zammit VC, Mitar DA, Whitworth JA. Renin-aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens 1992;5:366-71.
15. Symonds EM, Broughton Pipkin F, Craven DJ. Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol 1975;82:643-50.
16. Shojaati K, Causevic M, Kadereit B, et al. Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 2004;66:2322-8.
17. Ramírez-Salazar M, Romero-Gutiérrez G, Zaina S, et al. Relationship of aldosterone synthase gene (C-344T) and mineralocorticoid receptor (S810L) polymorphisms with gestational hypertension. J Hum Hypertens 2011;25:320-6.
18. Herse F, Dechend R, Harsem NK, et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007;49:604-11.
19. King AE, Critchley HO. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J Steroid Biochem Mol Biol 2010;120:116-26.
20. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27:939-58.
21. Liu J, Matsuo H, Laoag-Fernandez JB, et al. The effects of progesterone on apoptosis in the human trophoblast-derived HTR-8/SV neo cells. Mol Hum Reprod 2007;13:869-74.
22. Bischof P, Meisser A, Campana A, Tseng L. Effects of decidua-conditioned medium and insulin-like growth factor binding protein-1 on trophoblastic matrix metalloproteinases and their inhibitors. Placenta 1998;19:457-64.
23. Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol 2005;3:56-67.
24. Szekeres-Bartho J, Halasz M, Palkovics T. Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J Reprod Immunol 2009;83:60-4.
25. Dai B, Cao Y, Liu W, et al. Dual roles of progesterone in embryo implantation in mouse. Endocrine 2003;21:123-32.
26. Shimonovitz S, Hurwitz A, Hochner-Celnikier D, et al. Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. Am J Obstet Gynecol 1998;178:457-61.
27. Chen JZ, Wong MH, Brennecke SP, Keogh RJ. The effects of human chorionic gonadotrophin, progesterone and oestradiol on trophoblast function. Mol Cell Endocrinol 2011;342:73-80.
28. Uddin MN, Horvat D, Glaser SS, et al. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 2008;29:266-73.
29. Uddin MN, Horvat D, Glaser SS, et al. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem 2008;283:17946-53.
30. Siddiqui AH, Irani RA, Zhang W, et al. Angiotensin receptor agonistic autoantibody-mediated soluble Fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension 2013;61:472-9.